Symbol:
Tmod2
Name:
tropomodulin 2
RGD ID:
61948
Description:
Enables actin binding activity and tropomyosin binding activity. Predicted to be involved in actin filament organization; muscle contraction; and myofibril assembly. Predicted to act upstream of or within learning or memory; neuron-neuron synaptic transmission; and positive regulation of G protein-coupled receptor signaling pathway. Located in growth cone. Orthologous to human TMOD2 (tropomodulin 2); INTERACTS WITH 1-[(4-chlorophenyl)-phenylmethyl]-4-methylpiperazine; 17alpha-ethynylestradiol; 17beta-estradiol.
Type:
protein-coding
RefSeq Status:
PROVISIONAL
Previously known as:
N-Tmod; neuronal tropomodulin; tropomodulin-2
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Species
Gene symbol and name
Data Source
Assertion derived from
less info ...
Orthologs 1
Homo sapiens (human):
TMOD2 (tropomodulin 2)
HGNC
EggNOG, Ensembl, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, OrthoMCL, Panther, PhylomeDB, Treefam
Mus musculus (house mouse):
Tmod2 (tropomodulin 2)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chinchilla lanigera (long-tailed chinchilla):
Tmod2 (tropomodulin 2)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Pan paniscus (bonobo/pygmy chimpanzee):
TMOD2 (tropomodulin 2)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Canis lupus familiaris (dog):
TMOD2 (tropomodulin 2)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Ictidomys tridecemlineatus (thirteen-lined ground squirrel):
Tmod2 (tropomodulin 2)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Sus scrofa (pig):
TMOD2 (tropomodulin 2)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chlorocebus sabaeus (green monkey):
TMOD2 (tropomodulin 2)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Heterocephalus glaber (naked mole-rat):
Tmod2 (tropomodulin 2)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Alliance orthologs 3
Mus musculus (house mouse):
Tmod2 (tropomodulin 2)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Homo sapiens (human):
TMOD2 (tropomodulin 2)
Alliance
DIOPT (Ensembl Compara|HGNC|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Danio rerio (zebrafish):
tmod2 (tropomodulin 2)
Alliance
DIOPT (Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Caenorhabditis elegans (roundworm):
tmd-2
Alliance
DIOPT (OrthoFinder|PANTHER|PhylomeDB)
Drosophila melanogaster (fruit fly):
tmod
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Caenorhabditis elegans (roundworm):
unc-94
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Xenopus tropicalis (tropical clawed frog):
tmod2
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER)
Latest Assembly:
GRCr8 - GRCr8 Assembly
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 8 85,197,222 - 85,250,627 (-) NCBI GRCr8 mRatBN7.2 8 76,316,736 - 76,366,003 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 8 76,325,667 - 76,365,720 (-) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 8 81,833,194 - 81,859,701 (-) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 8 80,098,086 - 80,124,579 (-) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 8 77,932,534 - 77,959,043 (-) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 8 82,505,947 - 82,547,450 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 8 82,506,934 - 82,533,689 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 8 82,108,631 - 82,148,859 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 8 80,392,806 - 80,419,315 (-) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 8 80,411,859 - 80,438,369 (-) NCBI Celera 8 76,115,302 - 76,142,235 (-) NCBI Celera Cytogenetic Map 8 q24 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
Tmod2 Rat (+)-lariciresinol decreases expression ISO TMOD2 (Homo sapiens) 6480464 lariciresinol results in decreased expression of TMOD2 protein CTD PMID:27417256 Tmod2 Rat (-)-lariciresinol decreases expression ISO TMOD2 (Homo sapiens) 6480464 lariciresinol results in decreased expression of TMOD2 protein CTD PMID:27417256 Tmod2 Rat 1,2-dichloroethane decreases expression ISO Tmod2 (Mus musculus) 6480464 ethylene dichloride results in decreased expression of TMOD2 mRNA CTD PMID:28960355 Tmod2 Rat 1-[(4-chlorophenyl)-phenylmethyl]-4-methylpiperazine decreases expression EXP 6480464 chlorcyclizine results in decreased expression of TMOD2 mRNA CTD PMID:21058326 Tmod2 Rat 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of TMOD2 mRNA CTD PMID:29097150 Tmod2 Rat 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of TMOD2 mRNA CTD PMID:20068009 Tmod2 Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Tmod2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of TMOD2 mRNA CTD PMID:21570461 Tmod2 Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of TMOD2 mRNA CTD PMID:33387578 Tmod2 Rat 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:32109520 Tmod2 Rat 2,4-dibromophenyl 2,4,5-tribromophenyl ether decreases expression ISO Tmod2 (Mus musculus) 6480464 2 more ... CTD PMID:18550172 Tmod2 Rat 2,4-dibromophenyl 2,4,5-tribromophenyl ether increases expression ISO Tmod2 (Mus musculus) 6480464 2 more ... CTD PMID:18550172 Tmod2 Rat 3,3',5,5'-tetrabromobisphenol A decreases expression ISO Tmod2 (Mus musculus) 6480464 tetrabromobisphenol A results in decreased expression of TMOD2 mRNA CTD PMID:25172293 Tmod2 Rat 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO TMOD2 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of TMOD2 mRNA CTD PMID:28628672 Tmod2 Rat 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of TMOD2 mRNA CTD PMID:30047161 Tmod2 Rat acrylamide decreases expression ISO TMOD2 (Homo sapiens) 6480464 Acrylamide results in decreased expression of TMOD2 mRNA CTD PMID:32763439 Tmod2 Rat actinomycin D increases expression ISO TMOD2 (Homo sapiens) 6480464 Dactinomycin results in increased expression of TMOD2 mRNA CTD PMID:38460933 Tmod2 Rat actinomycin D multiple interactions ISO TMOD2 (Homo sapiens) 6480464 [Dactinomycin co-treated with nutlin 3] results in increased expression of TMOD2 mRNA CTD PMID:38460933 Tmod2 Rat aflatoxin B1 decreases methylation ISO TMOD2 (Homo sapiens) 6480464 Aflatoxin B1 results in decreased methylation of TMOD2 gene CTD PMID:27153756 Tmod2 Rat ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of TMOD2 mRNA CTD PMID:16483693 Tmod2 Rat benzo[a]pyrene increases expression ISO TMOD2 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased expression of TMOD2 mRNA CTD PMID:22316170 Tmod2 Rat benzo[a]pyrene increases methylation ISO TMOD2 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of TMOD2 5' UTR CTD PMID:27901495 Tmod2 Rat benzo[a]pyrene affects methylation ISO TMOD2 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of TMOD2 promoter CTD PMID:27901495 Tmod2 Rat benzo[a]pyrene increases expression ISO Tmod2 (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of TMOD2 mRNA CTD PMID:22610609 Tmod2 Rat benzo[b]fluoranthene increases expression ISO Tmod2 (Mus musculus) 6480464 benzo(b)fluoranthene results in increased expression of TMOD2 mRNA CTD PMID:26377693 Tmod2 Rat bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of TMOD2 mRNA CTD PMID:25181051 more ... Tmod2 Rat bisphenol A decreases expression ISO Tmod2 (Mus musculus) 6480464 bisphenol A results in decreased expression of TMOD2 mRNA CTD PMID:32156529 Tmod2 Rat bisphenol A increases expression ISO TMOD2 (Homo sapiens) 6480464 bisphenol A results in increased expression of TMOD2 protein CTD PMID:33376534 Tmod2 Rat bisphenol A decreases expression ISO TMOD2 (Homo sapiens) 6480464 bisphenol A results in decreased expression of TMOD2 mRNA CTD PMID:33670352 Tmod2 Rat bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of TMOD2 mRNA CTD PMID:29097150 Tmod2 Rat bisphenol A multiple interactions ISO TMOD2 (Homo sapiens) 6480464 [ginger extract results in increased abundance of Oils more ... CTD PMID:27156127 more ... Tmod2 Rat bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of TMOD2 gene CTD PMID:28505145 Tmod2 Rat butyric acid increases expression ISO TMOD2 (Homo sapiens) 6480464 Butyric Acid results in increased expression of TMOD2 mRNA CTD PMID:33770205 and PMID:34581912 Tmod2 Rat camptothecin increases expression ISO TMOD2 (Homo sapiens) 6480464 Camptothecin results in increased expression of TMOD2 mRNA CTD PMID:38460933 Tmod2 Rat CGP 52608 multiple interactions ISO TMOD2 (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to TMOD2 gene] CTD PMID:28238834 Tmod2 Rat chlorpyrifos decreases expression EXP 6480464 Chlorpyrifos results in decreased expression of TMOD2 mRNA CTD PMID:18668222 Tmod2 Rat cisplatin increases expression ISO TMOD2 (Homo sapiens) 6480464 Cisplatin results in increased expression of TMOD2 mRNA CTD PMID:27392435 Tmod2 Rat cisplatin multiple interactions ISO TMOD2 (Homo sapiens) 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of TMOD2 mRNA CTD PMID:27392435 Tmod2 Rat corosolic acid increases expression ISO TMOD2 (Homo sapiens) 6480464 corosolic acid results in increased expression of TMOD2 mRNA CTD PMID:37939859 Tmod2 Rat cyclosporin A decreases methylation ISO TMOD2 (Homo sapiens) 6480464 Cyclosporine results in decreased methylation of TMOD2 promoter CTD PMID:27989131 Tmod2 Rat dexamethasone multiple interactions ISO TMOD2 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of TMOD2 mRNA CTD PMID:28628672 Tmod2 Rat dibenz[a,h]anthracene increases expression ISO Tmod2 (Mus musculus) 6480464 1 more ... CTD PMID:26377693 Tmod2 Rat diuron decreases expression EXP 6480464 Diuron results in decreased expression of TMOD2 mRNA CTD PMID:25152437 Tmod2 Rat dorsomorphin multiple interactions ISO TMOD2 (Homo sapiens) 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 Tmod2 Rat epoxiconazole increases expression ISO Tmod2 (Mus musculus) 6480464 epoxiconazole results in increased expression of TMOD2 mRNA CTD PMID:35436446 Tmod2 Rat gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of TMOD2 mRNA CTD PMID:33387578 Tmod2 Rat indometacin multiple interactions ISO TMOD2 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of TMOD2 mRNA CTD PMID:28628672 Tmod2 Rat lead(0) affects splicing ISO TMOD2 (Homo sapiens) 6480464 Lead affects the splicing of TMOD2 mRNA CTD PMID:28903495 Tmod2 Rat lead(0) affects expression ISO TMOD2 (Homo sapiens) 6480464 Lead affects the expression of TMOD2 mRNA CTD PMID:28903495 Tmod2 Rat levonorgestrel multiple interactions ISO TMOD2 (Homo sapiens) 6480464 [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of TMOD2 mRNA CTD PMID:19074003 Tmod2 Rat lipopolysaccharide multiple interactions ISO TMOD2 (Homo sapiens) 6480464 [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of TMOD2 mRNA CTD PMID:35811015 Tmod2 Rat mercury dibromide increases expression ISO TMOD2 (Homo sapiens) 6480464 mercuric bromide results in increased expression of TMOD2 mRNA CTD PMID:26272509 Tmod2 Rat methimazole decreases expression EXP 6480464 Methimazole results in decreased expression of TMOD2 mRNA CTD PMID:30047161 Tmod2 Rat methylisothiazolinone decreases expression ISO TMOD2 (Homo sapiens) 6480464 2-methyl-4-isothiazolin-3-one results in decreased expression of TMOD2 mRNA CTD PMID:31629900 Tmod2 Rat methylmercury chloride decreases expression ISO TMOD2 (Homo sapiens) 6480464 methylmercuric chloride results in decreased expression of TMOD2 mRNA CTD PMID:28001369 Tmod2 Rat microcystin-LR decreases expression EXP 6480464 cyanoginosin LR results in decreased expression of TMOD2 protein CTD PMID:22430071 Tmod2 Rat N-methyl-4-phenylpyridinium increases expression ISO Tmod2 (Mus musculus) 6480464 1-Methyl-4-phenylpyridinium results in increased expression of TMOD2 protein CTD PMID:26558463 Tmod2 Rat N-nitrosodiethylamine multiple interactions EXP 6480464 caffeic acid phenethyl ester inhibits the reaction [Diethylnitrosamine results in increased expression of TMOD2 mRNA] CTD PMID:20360939 Tmod2 Rat N-nitrosodiethylamine increases expression EXP 6480464 Diethylnitrosamine results in increased expression of TMOD2 mRNA CTD PMID:20360939 Tmod2 Rat nickel atom decreases expression ISO TMOD2 (Homo sapiens) 6480464 Nickel results in decreased expression of TMOD2 mRNA CTD PMID:25583101 Tmod2 Rat nickel sulfate decreases expression ISO TMOD2 (Homo sapiens) 6480464 nickel sulfate results in decreased expression of TMOD2 mRNA CTD PMID:22714537 Tmod2 Rat Nutlin-3 multiple interactions ISO TMOD2 (Homo sapiens) 6480464 [Dactinomycin co-treated with nutlin 3] results in increased expression of TMOD2 mRNA CTD PMID:38460933 Tmod2 Rat ozone multiple interactions ISO Tmod2 (Mus musculus) 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of TMOD2 mRNA CTD PMID:34911549 Tmod2 Rat panobinostat multiple interactions ISO TMOD2 (Homo sapiens) 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TMOD2 mRNA CTD PMID:27188386 Tmod2 Rat panobinostat increases expression ISO TMOD2 (Homo sapiens) 6480464 panobinostat results in increased expression of TMOD2 mRNA CTD PMID:26272509 Tmod2 Rat paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of TMOD2 mRNA CTD PMID:33387578 Tmod2 Rat phenethyl caffeate multiple interactions EXP 6480464 caffeic acid phenethyl ester inhibits the reaction [Diethylnitrosamine results in increased expression of TMOD2 mRNA] CTD PMID:20360939 Tmod2 Rat phenylmercury acetate multiple interactions ISO TMOD2 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TMOD2 mRNA CTD PMID:27188386 Tmod2 Rat potassium chromate decreases expression ISO TMOD2 (Homo sapiens) 6480464 potassium chromate(VI) results in decreased expression of TMOD2 mRNA CTD PMID:22714537 Tmod2 Rat pregnenolone 16alpha-carbonitrile decreases expression EXP 6480464 Pregnenolone Carbonitrile results in decreased expression of TMOD2 mRNA CTD PMID:30047161 Tmod2 Rat resveratrol multiple interactions ISO TMOD2 (Homo sapiens) 6480464 [Plant Extracts co-treated with Resveratrol] results in increased expression of TMOD2 mRNA CTD PMID:23557933 Tmod2 Rat rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of TMOD2 protein CTD PMID:35544339 Tmod2 Rat S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO TMOD2 (Homo sapiens) 6480464 [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of TMOD2 mRNA CTD PMID:35811015 Tmod2 Rat SB 431542 multiple interactions ISO TMOD2 (Homo sapiens) 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 Tmod2 Rat sodium arsenite decreases expression ISO TMOD2 (Homo sapiens) 6480464 sodium arsenite results in decreased expression of TMOD2 mRNA CTD PMID:22714537 Tmod2 Rat sodium arsenite decreases expression ISO Tmod2 (Mus musculus) 6480464 sodium arsenite results in decreased expression of TMOD2 mRNA CTD PMID:36209798 Tmod2 Rat sodium arsenite affects methylation ISO TMOD2 (Homo sapiens) 6480464 sodium arsenite affects the methylation of TMOD2 gene CTD PMID:28589171 Tmod2 Rat Soman increases expression EXP 6480464 Soman results in increased expression of TMOD2 mRNA CTD PMID:19281266 Tmod2 Rat sulforaphane increases expression ISO TMOD2 (Homo sapiens) 6480464 sulforaphane results in increased expression of TMOD2 mRNA CTD PMID:26833863 Tmod2 Rat sunitinib decreases expression ISO TMOD2 (Homo sapiens) 6480464 Sunitinib results in decreased expression of TMOD2 mRNA CTD PMID:31533062 Tmod2 Rat testosterone undecanoate multiple interactions ISO TMOD2 (Homo sapiens) 6480464 [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of TMOD2 mRNA CTD PMID:19074003 Tmod2 Rat thimerosal increases expression ISO TMOD2 (Homo sapiens) 6480464 Thimerosal results in increased expression of TMOD2 mRNA CTD PMID:16870260 Tmod2 Rat titanium dioxide decreases expression ISO Tmod2 (Mus musculus) 6480464 titanium dioxide results in decreased expression of TMOD2 mRNA CTD PMID:23557971 and PMID:29264374 Tmod2 Rat titanium dioxide decreases methylation ISO Tmod2 (Mus musculus) 6480464 titanium dioxide results in decreased methylation of TMOD2 gene CTD PMID:35295148 Tmod2 Rat trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of TMOD2 mRNA CTD PMID:33387578 Tmod2 Rat trichostatin A increases expression ISO TMOD2 (Homo sapiens) 6480464 trichostatin A results in increased expression of TMOD2 mRNA CTD PMID:24935251 and PMID:26272509 Tmod2 Rat trichostatin A affects expression ISO TMOD2 (Homo sapiens) 6480464 trichostatin A affects the expression of TMOD2 mRNA CTD PMID:28542535 Tmod2 Rat trichostatin A multiple interactions ISO TMOD2 (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TMOD2 mRNA CTD PMID:27188386 Tmod2 Rat triptonide increases expression ISO Tmod2 (Mus musculus) 6480464 triptonide results in increased expression of TMOD2 mRNA CTD PMID:33045310 Tmod2 Rat valproic acid affects expression ISO TMOD2 (Homo sapiens) 6480464 Valproic Acid affects the expression of TMOD2 mRNA CTD PMID:25979313 Tmod2 Rat valproic acid multiple interactions ISO TMOD2 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of TMOD2 mRNA CTD PMID:27188386 Tmod2 Rat valproic acid increases expression ISO TMOD2 (Homo sapiens) 6480464 Valproic Acid results in increased expression of TMOD2 mRNA CTD PMID:23179753 more ... Tmod2 Rat zinc atom decreases expression ISO TMOD2 (Homo sapiens) 6480464 Zinc deficiency results in decreased expression of TMOD2 mRNA CTD PMID:18356318 Tmod2 Rat zinc(0) decreases expression ISO TMOD2 (Homo sapiens) 6480464 Zinc deficiency results in decreased expression of TMOD2 mRNA CTD PMID:18356318
(+)-lariciresinol (ISO) (-)-lariciresinol (ISO) 1,2-dichloroethane (ISO) 1-[(4-chlorophenyl)-phenylmethyl]-4-methylpiperazine (EXP) 17alpha-ethynylestradiol (EXP) 17beta-estradiol (EXP) 2,3,7,8-tetrachlorodibenzodioxine (EXP,ISO) 2,3,7,8-Tetrachlorodibenzofuran (EXP) 2,4-dibromophenyl 2,4,5-tribromophenyl ether (ISO) 3,3',5,5'-tetrabromobisphenol A (ISO) 3-isobutyl-1-methyl-7H-xanthine (ISO) 6-propyl-2-thiouracil (EXP) acrylamide (ISO) actinomycin D (ISO) aflatoxin B1 (ISO) ammonium chloride (EXP) benzo[a]pyrene (ISO) benzo[b]fluoranthene (ISO) bisphenol A (EXP,ISO) butyric acid (ISO) camptothecin (ISO) CGP 52608 (ISO) chlorpyrifos (EXP) cisplatin (ISO) corosolic acid (ISO) cyclosporin A (ISO) dexamethasone (ISO) dibenz[a,h]anthracene (ISO) diuron (EXP) dorsomorphin (ISO) epoxiconazole (ISO) gentamycin (EXP) indometacin (ISO) lead(0) (ISO) levonorgestrel (ISO) lipopolysaccharide (ISO) mercury dibromide (ISO) methimazole (EXP) methylisothiazolinone (ISO) methylmercury chloride (ISO) microcystin-LR (EXP) N-methyl-4-phenylpyridinium (ISO) N-nitrosodiethylamine (EXP) nickel atom (ISO) nickel sulfate (ISO) Nutlin-3 (ISO) ozone (ISO) panobinostat (ISO) paracetamol (EXP) phenethyl caffeate (EXP) phenylmercury acetate (ISO) potassium chromate (ISO) pregnenolone 16alpha-carbonitrile (EXP) resveratrol (ISO) rotenone (EXP) S-(1,2-dichlorovinyl)-L-cysteine (ISO) SB 431542 (ISO) sodium arsenite (ISO) Soman (EXP) sulforaphane (ISO) sunitinib (ISO) testosterone undecanoate (ISO) thimerosal (ISO) titanium dioxide (ISO) trichloroethene (EXP) trichostatin A (ISO) triptonide (ISO) valproic acid (ISO) zinc atom (ISO) zinc(0) (ISO)
Tmod2 (Rattus norvegicus - Norway rat)
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 8 85,197,222 - 85,250,627 (-) NCBI GRCr8 mRatBN7.2 8 76,316,736 - 76,366,003 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 8 76,325,667 - 76,365,720 (-) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 8 81,833,194 - 81,859,701 (-) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 8 80,098,086 - 80,124,579 (-) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 8 77,932,534 - 77,959,043 (-) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 8 82,505,947 - 82,547,450 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 8 82,506,934 - 82,533,689 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 8 82,108,631 - 82,148,859 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 8 80,392,806 - 80,419,315 (-) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 8 80,411,859 - 80,438,369 (-) NCBI Celera 8 76,115,302 - 76,142,235 (-) NCBI Celera Cytogenetic Map 8 q24 NCBI
TMOD2 (Homo sapiens - human)
Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 15 51,751,597 - 51,816,363 (+) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 15 51,751,597 - 51,816,363 (+) Ensembl GRCh38 hg38 GRCh38 GRCh37 15 52,043,794 - 52,108,560 (+) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 15 49,831,102 - 49,889,635 (+) NCBI NCBI36 Build 36 hg18 NCBI36 Build 34 15 49,831,101 - 49,889,634 NCBI Celera 15 28,937,177 - 29,001,954 (+) NCBI Celera Cytogenetic Map 15 q21.2 NCBI HuRef 15 28,874,266 - 28,939,046 (+) NCBI HuRef CHM1_1 15 52,161,794 - 52,226,629 (+) NCBI CHM1_1 T2T-CHM13v2.0 15 49,559,103 - 49,623,854 (+) NCBI T2T-CHM13v2.0
Tmod2 (Mus musculus - house mouse)
Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 9 75,472,903 - 75,518,620 (-) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 9 75,472,903 - 75,518,607 (-) Ensembl GRCm39 Ensembl GRCm38 9 75,565,621 - 75,611,342 (-) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 9 75,565,621 - 75,611,325 (-) Ensembl GRCm38 mm10 GRCm38 MGSCv37 9 75,413,428 - 75,459,132 (-) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 9 75,351,530 - 75,397,234 (-) NCBI MGSCv36 mm8 Celera 9 72,726,546 - 72,775,171 (-) NCBI Celera Cytogenetic Map 9 D NCBI cM Map 9 42.31 NCBI
Tmod2 (Chinchilla lanigera - long-tailed chinchilla)
Chinchilla Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChiLan1.0 Ensembl NW_004955409 2,808,543 - 2,842,844 (-) Ensembl ChiLan1.0 ChiLan1.0 NW_004955409 2,801,173 - 2,842,717 (-) NCBI ChiLan1.0 ChiLan1.0
TMOD2 (Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 16 40,985,905 - 41,053,274 (+) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 15 45,166,348 - 45,233,756 (+) NCBI NHGRI_mPanPan1 Mhudiblu_PPA_v0 15 30,690,641 - 30,757,960 (+) NCBI Mhudiblu_PPA_v0 Mhudiblu_PPA_v0 panPan3 PanPan1.1 15 49,035,929 - 49,087,467 (+) NCBI panpan1.1 PanPan1.1 panPan2 PanPan1.1 Ensembl 15 49,035,929 - 49,079,570 (+) Ensembl panpan1.1 panPan2
TMOD2 (Canis lupus familiaris - dog)
Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 30 17,425,216 - 17,501,484 (+) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 CanFam3.1 Ensembl 30 17,455,987 - 17,592,580 (+) Ensembl CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 30 17,351,455 - 17,420,147 (+) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 30 17,571,419 - 17,646,819 (+) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 Ensembl 30 17,588,331 - 17,740,756 (+) Ensembl ROS_Cfam_1.0 Ensembl UMICH_Zoey_3.1 30 17,492,670 - 17,561,539 (+) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 30 17,611,072 - 17,686,398 (+) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 30 17,717,590 - 17,785,938 (+) NCBI UU_Cfam_GSD_1.0
Tmod2 (Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
Squirrel Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl HiC_Itri_2 NW_024408640 95,742,038 - 95,794,177 (+) NCBI HiC_Itri_2 SpeTri2.0 Ensembl NW_004936471 13,602,732 - 13,729,228 (+) Ensembl SpeTri2.0 SpeTri2.0 Ensembl SpeTri2.0 NW_004936471 13,602,769 - 13,636,258 (+) NCBI SpeTri2.0 SpeTri2.0 SpeTri2.0
TMOD2 (Sus scrofa - pig)
Pig Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Sscrofa11.1 Ensembl 1 119,956,588 - 120,009,372 (-) Ensembl Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa11.1 1 119,956,583 - 120,009,372 (-) NCBI Sscrofa11.1 Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa10.2 1 133,216,996 - 133,269,777 (+) NCBI Sscrofa10.2 Sscrofa10.2 susScr3
TMOD2 (Chlorocebus sabaeus - green monkey)
Green Monkey Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChlSab1.1 26 31,560,112 - 31,624,967 (-) NCBI ChlSab1.1 ChlSab1.1 chlSab2 ChlSab1.1 Ensembl 26 31,568,024 - 31,624,905 (-) Ensembl ChlSab1.1 ChlSab1.1 Ensembl chlSab2 Vero_WHO_p1.0 NW_023666048 109,589,912 - 109,655,378 (+) NCBI Vero_WHO_p1.0 Vero_WHO_p1.0
Tmod2 (Heterocephalus glaber - naked mole-rat)
.
Predicted Target Of
Count of predictions: 28 Count of miRNA genes: 27 Interacting mature miRNAs: 28 Transcripts: ENSRNOT00000014124 Prediction methods: Miranda, Rnahybrid, Targetscan Result types: miRGate_prediction
1554321 Bmd3 Bone mineral density QTL 3 7.9 0.0001 femur mineral mass (VT:0010011) volumetric bone mineral density (CMO:0001553) 8 40952565 123900184 Rat 9590292 Uminl3 Urine mineral level QTL 3 3.62 0.001 urine mineral amount (VT:0015086) urine electrolyte level (CMO:0000593) 8 71888757 116888757 Rat 1578769 Uae31 Urinary albumin excretion QTL 31 3.3 0.001 urine albumin amount (VT:0002871) urine albumin excretion rate (CMO:0000757) 8 30848154 101699754 Rat 1298079 Activ2 Activity QTL 2 9.5 0.000001 voluntary movement trait (VT:0003491) rearing measurement (CMO:0001515) 8 41866876 86866876 Rat 70161 Bp62 Blood pressure QTL 62 2.9 0.001 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 8 42692684 90165460 Rat 1578765 Klgr1 Kidney lesion grade QTL 1 3.3 0.0001 kidney morphology trait (VT:0002135) organ lesion measurement (CMO:0000677) 8 30848154 101699754 Rat 1582222 Epfw2 Epididymal fat weight QTL 2 3.2 0.0005 epididymal fat pad mass (VT:0010421) epididymal fat pad weight to body weight ratio (CMO:0000658) 8 31737729 76737729 Rat 61464 Niddm11 Non-insulin dependent diabetes mellitus QTL 11 3.1 0.001 blood insulin amount (VT:0001560) plasma insulin level (CMO:0000342) 8 35582032 80582032 Rat 4889938 Bss89 Bone structure and strength QTL 89 3.8 tibia size trait (VT:0100001) tibia cortical bone volume (CMO:0001725) 8 50095249 82460899 Rat 1578755 Pur5 Proteinuria QTL 5 3.3 0.0001 urine total protein amount (VT:0000032) urine total protein excretion rate (CMO:0000756) 8 30848154 101699754 Rat 8662823 Vetf5 Vascular elastic tissue fragility QTL 5 1.9 artery integrity trait (VT:0010639) patent ductus arteriosus score (CMO:0002566) 8 28242912 99525068 Rat 2313088 Bss75 Bone structure and strength QTL 75 3.1 0.0001 body length (VT:0001256) body length, nose to rump (CMO:0000079) 8 30848154 82460899 Rat 631210 Bw3 Body weight QTL3 5.9 mesenteric fat pad mass (VT:0010427) mesenteric fat pad weight to body weight ratio (CMO:0000654) 8 69349194 112783834 Rat 1358896 Bp262 Blood pressure QTL 262 2.89 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 8 27205715 99103503 Rat 731182 Uae24 Urinary albumin excretion QTL 24 6.4 urine albumin amount (VT:0002871) urine albumin excretion rate (CMO:0000757) 8 19331152 93965294 Rat 8694446 Bw170 Body weight QTL 170 12.07 0.001 retroperitoneal fat pad mass (VT:0010430) retroperitoneal fat pad weight to body weight ratio (CMO:0000635) 8 71888757 116888757 Rat 737824 Hcar10 Hepatocarcinoma resistance QTL 10 2.9 liver integrity trait (VT:0010547) liver tumorous lesion number (CMO:0001068) 8 40713066 82925667 Rat 61358 Bp39 Blood pressure QTL 39 2 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 8 35551938 80551938 Rat 1358906 Bp253 Blood pressure QTL 253 4 0.0004 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 8 40713066 93965294 Rat 10450865 Bw175 Body weight QTL 175 4.1 total fat pad mass (VT:0015008) adipose tissue molecular composition measurement (CMO:0000484) 8 75311777 84531599 Rat 1358907 Cm40 Cardiac mass QTL 40 1.89 heart mass (VT:0007028) heart weight to body weight ratio (CMO:0000074) 8 27205715 99103503 Rat 70197 BpQTLcluster8 Blood pressure QTL cluster 8 3.482 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 8 46531639 119088626 Rat 2316950 Scl66 Serum cholesterol level QTL 66 4.1 blood cholesterol amount (VT:0000180) plasma total cholesterol level (CMO:0000585) 8 30848259 105647037 Rat 1582254 Kidm31 Kidney mass QTL 31 3 kidney mass (VT:0002707) both kidneys wet weight (CMO:0000085) 8 54237644 85365202 Rat 10402857 Bp380 Blood pressure QTL 380 0.95 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 8 53968765 98968765 Rat 1358892 Kidm26 Kidney mass QTL 26 3.69 kidney mass (VT:0002707) both kidneys wet weight to body weight ratio (CMO:0000340) 8 27205715 99103503 Rat 5684973 Bss100 Bone structure and strength QTL 100 4.7 tibia area (VT:1000281) tibia area measurement (CMO:0001382) 8 50095249 82460899 Rat 1582243 Bw66 Body weight QTL 66 3.4 0.0048 body mass (VT:0001259) body weight (CMO:0000012) 8 54237644 85365202 Rat 8694200 Abfw4 Abdominal fat weight QTL 4 9.07 0.001 visceral adipose mass (VT:0010063) abdominal fat pad weight to body weight ratio (CMO:0000095) 8 71888757 116888757 Rat 2313057 Bss76 Bone structure and strength QTL 76 3 0.0001 tibia size trait (VT:0100001) tibia midshaft cross-sectional area (CMO:0001717) 8 30848154 82460899 Rat 12879878 Bw183 Body weight QTL 183 0.001 body mass (VT:0001259) body weight (CMO:0000012) 8 43296169 98968765 Rat 1300177 Cm2 Cardiac mass QTL 2 3.65 heart mass (VT:0007028) heart weight (CMO:0000017) 8 54259986 100382532 Rat 1549909 Stresp11 Stress response QTL 11 6.83 0.0019 stress-related behavior trait (VT:0010451) number of approaches toward negative stimulus before onset of defensive burying response (CMO:0001960) 8 73473045 118473045 Rat 1549908 Neudeg1 Neurodegradation QTL 1 5.5 0 nervous system integrity trait (VT:0010566) logarithm of the ratio of the lesioned side motor neuron count to contralateral side motor neuron count (CMO:0001986) 8 30188867 94457446 Rat 12879879 Cm99 Cardiac mass QTL 99 0.001 heart mass (VT:0007028) heart weight to body weight ratio (CMO:0000074) 8 43296169 98968765 Rat 2313067 Bss77 Bone structure and strength QTL 77 3.1 0.0001 tibia size trait (VT:0100001) tibia midshaft endosteal cross-sectional area (CMO:0001716) 8 30848154 82460899 Rat 12879880 Cm100 Cardiac mass QTL 100 0.001 heart left ventricle mass (VT:0007031) heart left ventricle weight to body weight ratio (CMO:0000530) 8 43296169 98968765 Rat 12879881 Cm101 Cardiac mass QTL 101 0.001 heart right ventricle mass (VT:0007033) heart right ventricle weight to body weight ratio (CMO:0000914) 8 43296169 98968765 Rat 12879882 Am8 Aortic mass QTL 8 0.001 aorta mass (VT:0002845) aorta weight to aorta length to body weight ratio (CMO:0002722) 8 43296169 98968765 Rat 12879883 Kidm65 Kidney mass QTL 65 0.001 kidney mass (VT:0002707) both kidneys wet weight to body weight ratio (CMO:0000340) 8 43296169 98968765 Rat 1358912 Bw51 Body weight QTL 51 2.95 body mass (VT:0001259) body weight (CMO:0000012) 8 51351728 107062046 Rat 634332 Pia18 Pristane induced arthritis QTL 18 4 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 8 75311938 82925521 Rat 1300171 Bp184 Blood pressure QTL 184 3.66 arterial blood pressure trait (VT:2000000) blood pressure time series experimental set point of the baroreceptor response (CMO:0002593) 8 70513503 118219066 Rat 2313086 Bss60 Bone structure and strength QTL 60 4.1 0.0001 tibia length (VT:0004357) tibia length (CMO:0000450) 8 50095249 82460899 Rat 2303171 Bp331 Blood pressure QTL 331 5.57 0.005 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 8 61290298 119084929 Rat 2293697 Bmd39 Bone mineral density QTL 39 femur strength trait (VT:0010010) femur total energy absorbed before break (CMO:0001677) 8 54043744 98968765 Rat 1331837 Bw23 Body weight QTL 23 4.19 0.00007 body mass (VT:0001259) body weight (CMO:0000012) 8 46531722 99083736 Rat 1331838 Niddm61 Non-insulin dependent diabetes mellitus QTL 61 3.53 0.0004 blood insulin amount (VT:0001560) plasma insulin level (CMO:0000342) 8 36469535 99083736 Rat 631650 Stl6 Serum triglyceride level QTL 6 4 0.0019 blood triglyceride amount (VT:0002644) plasma triglyceride level (CMO:0000548) 8 10378157 112202585 Rat 631653 Bp125 Blood pressure QTL 125 3.3 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 8 66142385 111142385 Rat 1581557 Eae16 Experimental allergic encephalomyelitis QTL 16 3.8 nervous system integrity trait (VT:0010566) experimental autoimmune encephalomyelitis incidence/prevalence measurement (CMO:0001046) 8 8462195 110921472 Rat 631271 Lecl1 Lens clarity QTL 1 0.001 lens clarity trait (VT:0001304) age of onset/diagnosis of cataract (CMO:0001584) 8 18984168 84531599 Rat 2303570 Gluco48 Glucose level QTL 48 2 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 8 49805831 94805831 Rat 2313046 Bss78 Bone structure and strength QTL 78 3.5 0.0001 tibia strength trait (VT:1000284) tibia total energy absorbed before break (CMO:0001736) 8 30848154 82460899 Rat 2301402 Bp316 Blood pressure QTL 316 0.005 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 8 53968765 98968765 Rat 631664 Hcar3 Hepatocarcinoma resistance QTL 3 2.9 0.0005 liver integrity trait (VT:0010547) volume of individual liver tumorous lesion (CMO:0001078) 8 54237644 99103503 Rat 8694392 Bw161 Body weight QTL 161 8.06 0.001 body lean mass (VT:0010483) lean tissue morphological measurement (CMO:0002184) 8 71888757 116888757 Rat
AW535177
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 8 76,325,756 - 76,325,912 (+) MAPPER mRatBN7.2 Rnor_6.0 8 82,507,145 - 82,507,300 NCBI Rnor6.0 Rnor_5.0 8 82,109,829 - 82,109,984 UniSTS Rnor5.0 RGSC_v3.4 8 80,392,896 - 80,393,051 UniSTS RGSC3.4 Celera 8 76,115,392 - 76,115,547 UniSTS RH 3.4 Map 8 925.69 UniSTS Cytogenetic Map 8 q24 UniSTS
RH138018
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 8 76,344,654 - 76,344,827 (+) MAPPER mRatBN7.2 Rnor_6.0 8 82,526,081 - 82,526,253 NCBI Rnor6.0 Rnor_5.0 8 82,127,490 - 82,127,662 UniSTS Rnor5.0 RGSC_v3.4 8 80,411,717 - 80,411,889 UniSTS RGSC3.4 Celera 8 76,134,637 - 76,134,809 UniSTS RH 3.4 Map 8 925.59 UniSTS Cytogenetic Map 8 q24 UniSTS
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
alimentary part of gastrointestinal system
9
11
49
113
76
75
44
25
44
6
203
97
93
45
60
31
Too many to show, limit is 500. Download them if you would like to view them all.
Ensembl Acc Id:
ENSRNOT00000014124 ⟹ ENSRNOP00000014124
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 8 76,325,667 - 76,352,253 (-) Ensembl Rnor_6.0 Ensembl 8 82,506,934 - 82,533,689 (-) Ensembl
Ensembl Acc Id:
ENSRNOT00000118239 ⟹ ENSRNOP00000079258
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 8 76,327,796 - 76,365,720 (-) Ensembl
RefSeq Acc Id:
NM_031613 ⟹ NP_113801
RefSeq Status:
PROVISIONAL
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 8 85,206,153 - 85,232,736 (-) NCBI mRatBN7.2 8 76,325,667 - 76,352,253 (-) NCBI Rnor_6.0 8 82,507,055 - 82,533,679 (-) NCBI Rnor_5.0 8 82,108,631 - 82,148,859 (-) NCBI RGSC_v3.4 8 80,392,806 - 80,419,315 (-) RGD Celera 8 76,115,302 - 76,142,235 (-) RGD
Sequence:
TCTCAGGAAGCTGGCCCACTTGAAGGTGTGAGAGGAAGGTGAGAGGAAGGTGTAACCATGGCGCTCCCCTTTCAGAAAGGGCTGGAGAAATACAAGAACATCGACGAGGACGAGCTTCTTGGCAAACT CTCAGAAGAGGAACTGAAACAGTTGGAAAATGTTCTAGATGACCTAGATCCCGAGAGTGCAACACTACCGGCTGGATTCCGACAGAAAGACCAGACCCAGAAAGCAGCCACTGGCCCATTTGACCGTG AGCATCTGCTCATGTATCTGGAGAAAGAGGCTTTGGAACAGAAAGACAGGGAGGATTTCGTACCCTTCACAGGAGAAAAGAAAGGGAGAGTCTTTATTCCCAAGGAAAAGCCTGTAGAAACTCGTAAA GAAGAGAAAGTGACTCTGGACCCAGAACTGGAGGAAGCCTTGGCCAGCGCCTCAGACACTGAACTCTACGACCTTGCAGCTGTCCTTGGAGTCCACAATTTGCTCAACAATCCGAAGTTTGATGAAGA AACAACCAATGGCCAAGGCCGCAAGGGGCCGGTGAGGAATGTCGTCAAAGGTGAAAAGGCCAAGCCGGTGTTTGAGGAGCCACCGAACCCCACAAATGTGGAAGCAAGCCTGCAGCAGATGAAAGCCA ACGACCCCAGCCTGCAGGAGGTCAACCTCAACAACATTAAGAACATTCCAATTCCAACCCTGAAGGAGTTTGCAAAGGCTCTGGAGACCAACACCCACGTGAGGAAGTTCAGCCTGGCCGCAACCCGA AGCAATGACCCTGTGGCCCTGGCCTTTGCAGAGATGCTGAAGGTCAACAAGACCTTGAAAAGTCTGAATGTAGAGTCCAATTTTATCACCGGCGCTGGGATCCTGGCCCTGGTGGAAGCGCTGCGGGA GAATGACACCTTGACAGAGATCAAGATCGACAACCAGAGGCAGCAGTTGGGAACAGCCGTGGAGATGGAGATCGCCCAGATGCTGGAGGAGAACTCAAGGATCCTCAAGTTTGGGTACCAGTTTACCA AGCAAGGGCCACGGACAAGAGTGGCAGCTGCCATCACAAAAAATAATGACCTAGTTCGCAAGAAGAGAGTTGAAGGAGACAGGAGGTAAACCTCCACTAAAAGAGGTGACGTCTCACCATGCGGCCAT CCAGAAAACATACACACAATCTTCCTCTTCTCCACGGG
hide sequence
RefSeq Acc Id:
XM_006243407 ⟹ XP_006243469
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 8 85,197,222 - 85,250,627 (-) NCBI mRatBN7.2 8 76,316,736 - 76,366,003 (-) NCBI Rnor_6.0 8 82,505,947 - 82,547,450 (-) NCBI Rnor_5.0 8 82,108,631 - 82,148,859 (-) NCBI
Sequence:
GGCTCCACCTGCTTCGCAGCGCGCTGGCGCACAAAGCTCTAGATTCTACGGGAGGACCCTGAGA GGCCAGCGTGTCATCAGTAGACTCAGCGGCCCGGGCAGGGGTCCTGTCCCAGTGTGGCCACCGCGCGTCGCCGGAACTACGCTTCCCAGGCTGCCCCGCTGCAGCCGCGCGCCCCGCGCCCCGCGCCG CGCCGGGCCGGGAGCCGCCTGTTGATCTCAGCTCTAGACCGGGGCTACGGCAACGCCCCTGATTGTCGGACCCGCGTACTCCGGGCTCTAAGGCTGCTGGCCAGGACCTTCCGCTTCGGGATGGGCGC AAGCAAGGTGGTAGTGTGAAGTCTCAGGAAGCTGGCCCACTTGAAGGTGTGAGAGGAAGGTGAGAGGAAGGTGTAACCATGGCGCTCCCCTTTCAGAAAGGGCTGGAGAAATACAAGAACATCGACGA GGACGAGCTTCTTGGCAAACTCTCAGAAGAGGAACTGAAACAGTTGGAAAATGTTCTAGATGACCTAGATCCCGAGAGTGCAACACTACCGGCTGGATTCCGACAGAAAGACCAGACCCAGAAAGCAG CCACTGGCCCATTTGACCGTGAGCATCTGCTCATGTATCTGGAGAAAGAGGCTTTGGAACAGAAAGACAGGGAGGATTTCGTACCCTTCACAGGAGAAAAGAAAGGGAGAGTCTTTATTCCCAAGGAA AAGCCTGTAGAAACTCGTAAAGAAGAGAAAGTGACTCTGGACCCAGAACTGGAGGAAGCCTTGGCCAGCGCCTCAGACACTGAACTCTACGACCTTGCAGCTGTCCTTGGAGTCCACAATTTGCTCAA CAATCCGAAGTTTGATGAAGAAACAACCAATGGCCAAGGCCGCAAGGGGCCGGTGAGGAATGTCGTCAAAGGTGAAAAGGCCAAGCCGGTGTTTGAGGAGCCACCGAACCCCACAAATGTGGAAGCAA GCCTGCAGCAGATGAAAGCCAACGACCCCAGCCTGCAGGAGGTCAACCTCAACAACATTAAGAACATTCCAATTCCAACCCTGAAGGAGTTTGCAAAGGCTCTGGAGACCAACACCCACGTGAGGAAG TTCAGCCTGGCCGCAACCCGAAGCAATGACCCTGTGGCCCTGGCCTTTGCAGAGATGCTGAAGGTCAACAAGACCTTGAAAAGTCTGAATGTAGAGTCCAATTTTATCACCGGCGCTGGGATCCTGGC CCTGGTGGAAGCGCTGCGGGAGAATGACACCTTGACAGAGATCAAGATCGACAACCAGAGGCAGCAGTTGGGAACAGCCGTGGAGATGGAGATCGCCCAGATGCTGGAGGAGAACTCAAGGATCCTCA AGTTTGGGTACCAGTTTACCAAGCAAGGGCCACGGACAAGAGTGGCAGCTGCCATCACAAAAAATAATGACCTAGTTCGCAAGAAGAGAGTTGAAGGAGACAGGAGGTAAACCTCCACTAAAAGAGGT GACGTCTCACCATGCGGCCATCCAGAAAAACATACACACAATCTTCCTCTTCTCCACGGGACCATTCTGTCTAAGGCTGTTCGTTTCCGTTAACCATATCCGTCATAATTGTAACTGTCACTCTTTTT TTAGCGCTACTTGTTTATCCAAGGTTCTGAAGTGTGTGTAGCAGTCTGCCTCGCTCCTGGACACGCTTGGTGGCTTGTACAAGTAGGAGGATACAGATCTTAAGACAGTGACAACACTGGAGATGATC TTAGCCACTTCCCTATTGGGTTGCCTCGCTTTCTTATGTGAACCTTTTTTAATCGTGGAAAGGGACTTAGCGTGTAGCATGTGTTTGTCGCTGACTGCACAGTGGAAGCCTATCTCTGTTTACACACA CGGCTTCGAGATAGGCTTGAGTTCATGAGAAGTGTGTGCGACTGACCACACAAGAAGTTAGTATTGCCAGTCTTTCACAAATTCTCCGTTAATTCCAGAAAGAAAAAAAAAAGTGTCTCTACATGCAT GTGTCCAGCTGATAGATGGTCAGTGGGATCTCCTTAGAAAGCACTTTAACGTAGCACTAGCAAAAGGACTGTTTATTACCCCATGATTTATTAATAACTCACACACTTACCTTTACTGACTTTTAAAC ATGAGTTAAACATATTTGTTTAGGTGTGTGGTACTGGGAACTGTACCCTGGGCCCTGTGCATGCTGGGCAAGCACTCTACTCCTCAGCTCCATCTCCAGCCCGAGTTATATTTAAAATGATTCTCTAA TAGGAACTATTCACAAAGCCATTGAAAGACTTTTCAATGGGAAACTTTTAAATTTTTTCTAAAAGAAAATTTCAAAATGGTACATTCCCAAGTAAAACAACTATAACAGTGTCTTAGGGGCGAGAGAA ATGGCTCAGCCGTTAAAAGTGCTTGCTACTTTTCCAGAGGACCGGAGTTCAGTTTCAGCACCCGGGCTGAGCAGCTAACAATAGTGTATAACTCCATCTTCTGAGGGATGCGATGTCTCCAGCCTCTG AGGGCATCCACACATATGTGTACTTACCACCCCCATGTCATACACATGATTAAAAATAGACTTAAAAGATATGGCACCTTAATCAAAGTTTCTGGTACACAGTGAATTTGACAGTGAATTAAATGAAT TTGACAAATTTTAAAA
hide sequence
RefSeq Acc Id:
XM_006243408 ⟹ XP_006243470
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 8 85,197,222 - 85,233,300 (-) NCBI mRatBN7.2 8 76,316,736 - 76,352,805 (-) NCBI Rnor_6.0 8 82,505,947 - 82,537,445 (-) NCBI Rnor_5.0 8 82,108,631 - 82,148,859 (-) NCBI
Sequence:
AACAACAACAATAATGTAGCCGGGTTTGGTTGTGTGCCTGTAGTTAACATCACTCGGGCTGAGG AACGAGAACTGTAAACCAGCTCTAGGCCTACCCAGTGAAAATTTCCAGGCTAGCCTAGGCCATAGTACAAGAGCTTGTCTCGAACAAAACAACTCACCAATAATTCAAGGTTCTCTTTGAACCTTCAG ATCAGATTTGTGCTCTAAACAGACACAACTCTCTTTTCCCCTCTGGCTCTGAGACCCCCACCTCCCCAGCACCTTGCTATAGTATATGAAGTTTGCTTTGATAAACCACTGTTGGTGGTTTAATTAGG ACTGTTATTGCTTGGTGTTCTTTCCCTTGTGGATTACAGTTTGCACCCAGTACCATCTGTTTGGTCCGCTGCTGAGTCCCAACAGTGTTAGGAGAAGGTGGCCCCCAATATACATTTGTTAAATGAAT ATCCAAGCCTGAACTTGAGAAATCCGGGAGCAGTGAGAATTATGATACAGTTCCCTGCTTCCTGGGAGGTTGTGGTGTCTGGAGAGAGAGCGTGACATGCGTGAAAGAGAACGAGTGATAACTGTTAA GTAGGTGGCATAGGCAAAGCAAATTCAGGGAGGAGCAAATCCTGTGGGCTTAGGTGACCTCAGCAGGCTCCACGGAGGGGTAGGGCTGAGGGGAAAAGATGGCTGCCATGGAAAGATCTCTGGACCCA CATCCCCCTCACTAGTGTGAGCTCATTTCCTTCGTTTGACATCAACATTTATTGTGTGTCTACTGTGGGTCAAGATCTGTGCTGGGAGCCAAGATTTTATTGGTGAATAAATGGTATACAATATCCAA CCTCACAGAGATTAGCTAATAACTAATGTGCTGAAGCCAAGTTGTAGTCAAGGGGGTTACTATAGGGACAGCAAGTGACCCAGATTTTGACTCAGGGTCTGATCTGATTGAAGAAATAAAGCTCTCAT TGACACTGGAAGATGAGTCTGTAGTGGGATACAAGTAGGGTTCTTAGTGCTCTGAGCAGAGAGATGTGCATTTATGTTCCAGGAATTGGAAATGGTCCAAGGCTGGATCCAGGAGGACATTGGAGATG CAGTGCAGGGAGGGGGATAGAACTGCAGAGGCCTGAGTGTGAGTTTGGACTGCATCCTCGGGGTAACCAGAAGCCACTGGGGGATTGCAAAATGACTGAAATAAAGGTAATCAAGAGATCCCTTTGAC CTCTGTGTGCAGAACAATCAGAAGGTGAGGGGCTGGGCCTGGACATGGATGGAGATGTAGATGAGGTTCCCCATCATTGTGTAAGGATAGGACTTGGTGAATACTACACAGAAGGGTGGGGAAGGAAA AATGGCCAGGATGACACCATGGCTTCTGAAACAACTTCCTGAAATTCTAGAGGAGGAAAGGGCAAATGCGGGCTCCTCTGCTGAATTTTCAGGGTCTGATGACAGAGAAGAGTGAGGAGAGAGAGAAA GCCCAGAGCTGGCTGTGTGGCTGGGCTGAATGGCCCACAGCCTCCCTCACTCAATCCTGTGGTCCTGCAGAGCTCAGGATCTTAGCCAGGCCTCAGAGGCGGTGCACAAAGAGAAGGGGGGACATTCC AAGCCATGGTGCCACATCTGCCAACTTCCCGACAAGAGACAGAGGGTGGGCTCAGACCGAATAACTTGGGGGAGATTTCAATAAAGAGGCTATTTACAAGGGTGTGGGAAGCTTTAGGGAATCAACAA GGCAGAAATCTGGCAAGAGTCATCACAGAGACCCTTTGCCACCCCAAGGCCTGGAGCCAGCAAGACCTTGGGGAGACACGGTCATCTGAAGCACCCTCTCCGTACCCTCTCCGCCCTCACCCCGACCA TGTCCTCCTCTTTGCTGCTGGTGCCTCCTGTCGGTCAAACAAAAGGCAGAAACAGCAGCCTGAGGCAGATGTACTCCTGAGTCACAGCACCTTGATAGAGCACCGTGGACAGCAGAAACAGAAGGAGG AACCGAGGATTCTAGAACAGTTACCCTGGAATTGAGAGCATTTGGGAGAGAGTATTTTAGTTTCTGTATTGCAGTTGTGACAAAGAACAAAGTCATTTGCTTAAAACAATATGAATATGTTGACCCTT CAGTTAGAGAGTCAAATGGATCCTGCCGGTATCAGCGAGACATTTTTGCTCTCTAAAGGCTGTAGGGGGGAAAGTCTTCTCTTCTCGTTCCTCTTCTCGTGCCCCTTCCTGCATCTTCAAAGCCCCAA ATCATGATGTTCTGACCATGTTCTGTTCCAGCCATGACCATTTGGCTTTCCCTTCTGTCACCTGAATACTTTAGAGTAAATCGTGACCACTCAGATGATGCAGAATACTTTCCCTGTGAGAGGCCCTT AATCTAGAGCAGGAGAGCTAGCTCAGTTGGTAAGATCCAGGTTCCTAAGGTGTAGTACATAACTTTCACCAACATCCCATCTCCCCCAGTCAACCAATCTTCCTCCTAGCCACCCCAACCCATTCCAC CAACCCACCATGCACTTTCCTATCCTGCGTTTTTGTGTAGGCCCTGGTCTATCCTAGATGGCTCTTGCACATGCACGTCCCCGCTTAGGACCTTTTCCTTCAAGACACAATGACAGTCTCCTTTCCGG ATGACTCTCAAAGCTCCCCTTCCCTTACCCAACAGTTTTCAACCTACTTCAGACATTATTATAACACTACATGGCATCTGTGTGTCTGTCTCACTAAGCTCTGACCTTCCTGGAGGGAGCTTCTCTAG AGCTGTACTTGGCAGCAGGAATACAGCAAATCCTTACTGCATTGAAAGAGCTGACTGAACGCAGAATGCAGAGTTGTCTTCGTAGGGAAGATCTGTTGATTTTTCCTCAAGGGACCAAGTAAAACTTG CATTAGGCATGAAAGTTCGGGAACGAGGCATTTCAGAGGAGTGGAAGGCTGGAAAAGCATGCCTTAGGAGTATAAAGAGCAATTAGGAAGAACGACTGCAGAATTACTAGTCCAAAGAGGACATGAAG CTGGGAGGGAGGTGGGGTGGGGCACTAGGAGGTGTTGGACGGAGGTAGTCGTGTATAGAAGAGATCGAAGGATGTTATTTAAAGGTAGGAACTCTCAAGTGAATTAAAAGAAAACTATTAGAATACTC TCAAAGACATCATTAAAAATGGAAGATAAGGAAAGAAGAAGAAACAAGAGAGAGTTAACTGTGTGAAGAGAGCTTTAGAATGTCTCTTGGTTTCATTGCATGGACTTAAGGGACAACGTGTTCTCACC CAGAGCCTCTAAACTCTTTCCTCAATGAGTCCCATTCTGTGTTCTTCACAGCACTCTCCACCCTGAAAGGGCACAAGTATGCTGCTTACAACTGCCATACAATTAGTCATTGTTCTTCACTGTTTTCA ATGGAGAGCAAGGAGAGGCTTTGTAGTAGAGTGGAAAAGCACTCACTACCCTGGGAACCAGAAGCCAGGCACACCTCCAGTAGCAAGGTCTCTGGTCACCACCTGCTCAGTCGAGGTCTGTAAAATCC AACATCCAGTGACGGTGTCGTGCAGCCTTCCTTACAGGGCTGCTCTAAGGGGGGAAATGGTTGGGATAACATGCTGTGTGTGAAAATACAGCAAGCTGCGGTCGGCTCTGGAAACTAAGTGGTAGTGT GAAGTCTCAGGAAGCTGGCCCACTTGAAGGTGTGAGAGGAAGGTGAGAGGAAGGTGTAACCATGGCGCTCCCCTTTCAGAAAGGGCTGGAGAAATACAAGAACATCGACGAGGACGAGCTTCTTGGCA AACTCTCAGAAGAGGAACTGAAACAGTTGGAAAATGTTCTAGATGACCTAGATCCCGAGAGTGCAACACTACCGGCTGGATTCCGACAGAAAGACCAGACCCAGAAAGCAGCCACTGGCCCATTTGAC CGTGAGCATCTGCTCATGTATCTGGAGAAAGAGGCTTTGGAACAGAAAGACAGGGAGGATTTCGTACCCTTCACAGGAGAAAAGAAAGGGAGAGTCTTTATTCCCAAGGAAAAGCCTGTAGAAACTCG TAAAGAAGAGAAAGTGACTCTGGACCCAGAACTGGAGGAAGCCTTGGCCAGCGCCTCAGACACTGAACTCTACGACCTTGCAGCTGTCCTTGGAGTCCACAATTTGCTCAACAATCCGAAGTTTGATG AAGAAACAACCAATGGCCAAGGCCGCAAGGGGCCGGTGAGGAATGTCGTCAAAGGTGAAAAGGCCAAGCCGGTGTTTGAGGAGCCACCGAACCCCACAAATGTGGAAGCAAGCCTGCAGCAGATGAAA GCCAACGACCCCAGCCTGCAGGAGGTCAACCTCAACAACATTAAGAACATTCCAATTCCAACCCTGAAGGAGTTTGCAAAGGCTCTGGAGACCAACACCCACGTGAGGAAGTTCAGCCTGGCCGCAAC CCGAAGCAATGACCCTGTGGCCCTGGCCTTTGCAGAGATGCTGAAGGTCAACAAGACCTTGAAAAGTCTGAATGTAGAGTCCAATTTTATCACCGGCGCTGGGATCCTGGCCCTGGTGGAAGCGCTGC GGGAGAATGACACCTTGACAGAGATCAAGATCGACAACCAGAGGCAGCAGTTGGGAACAGCCGTGGAGATGGAGATCGCCCAGATGCTGGAGGAGAACTCAAGGATCCTCAAGTTTGGGTACCAGTTT ACCAAGCAAGGGCCACGGACAAGAGTGGCAGCTGCCATCACAAAAAATAATGACCTAGTTCGCAAGAAGAGAGTTGAAGGAGACAGGAGGTAAACCTCCACTAAAAGAGGTGACGTCTCACCATGCGG CCATCCAGAAAAACATACACACAATCTTCCTCTTCTCCACGGGACCATTCTGTCTAAGGCTGTTCGTTTCCGTTAACCATATCCGTCATAATTGTAACTGTCACTCTTTTTTTAGCGCTACTTGTTTA TCCAAGGTTCTGAAGTGTGTGTAGCAGTCTGCCTCGCTCCTGGACACGCTTGGTGGCTTGTACAAGTAGGAGGATACAGATCTTAAGACAGTGACAACACTGGAGATGATCTTAGCCACTTCCCTATT GGGTTGCCTCGCTTTCTTATGTGAACCTTTTTTAATCGTGGAAAGGGACTTAGCGTGTAGCATGTGTTTGTCGCTGACTGCACAGTGGAAGCCTATCTCTGTTTACACACACGGCTTCGAGATAGGCT TGAGTTCATGAGAAGTGTGTGCGACTGACCACACAAGAAGTTAGTATTGCCAGTCTTTCACAAATTCTCCGTTAATTCCAGAAAGAAAAAAAAAAGTGTCTCTACATGCATGTGTCCAGCTGATAGAT GGTCAGTGGGATCTCCTTAGAAAGCACTTTAACGTAGCACTAGCAAAAGGACTGTTTATTACCCCATGATTTATTAATAACTCACACACTTACCTTTACTGACTTTTAAACATGAGTTAAACATATTT GTTTAGGTGTGTGGTACTGGGAACTGTACCCTGGGCCCTGTGCATGCTGGGCAAGCACTCTACTCCTCAGCTCCATCTCCAGCCCGAGTTATATTTAAAATGATTCTCTAATAGGAACTATTCACAAA GCCATTGAAAGACTTTTCAATGGGAAACTTTTAAATTTTTTCTAAAAGAAAATTTCAAAATGGTACATTCCCAAGTAAAACAACTATAACAGTGTCTTAGGGGCGAGAGAAATGGCTCAGCCGTTAAA AGTGCTTGCTACTTTTCCAGAGGACCGGAGTTCAGTTTCAGCACCCGGGCTGAGCAGCTAACAATAGTGTATAACTCCATCTTCTGAGGGATGCGATGTCTCCAGCCTCTGAGGGCATCCACACATAT GTGTACTTACCACCCCCATGTCATACACATGATTAAAAATAGACTTAAAAGATATGGCACCTTAATCAAAGTTTCTGGTACACAGTGAATTTGACAGTGAATTAAATGAATTTGACAAATTTTAAAA
hide sequence
RefSeq Acc Id:
XM_008766331 ⟹ XP_008764553
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 8 85,197,222 - 85,245,899 (-) NCBI mRatBN7.2 8 76,316,736 - 76,365,405 (-) NCBI Rnor_6.0 8 82,505,947 - 82,546,679 (-) NCBI
Sequence:
CCCGGGAGCTGTCACAAGGACGCATCAGCCTTCAGAAAGCCTCCCTGGACAGGTCCCAGACAATCTTGTCTTATTCTTCCCGGTTAAAATCATGCTGTGGTAGTGTGAAGTCTCAGGAAGCTGGCCCA CTTGAAGGTGTGAGAGGAAGGTGAGAGGAAGGTGTAACCATGGCGCTCCCCTTTCAGAAAGGGCTGGAGAAATACAAGAACATCGACGAGGACGAGCTTCTTGGCAAACTCTCAGAAGAGGAACTGAA ACAGTTGGAAAATGTTCTAGATGACCTAGATCCCGAGAGTGCAACACTACCGGCTGGATTCCGACAGAAAGACCAGACCCAGAAAGCAGCCACTGGCCCATTTGACCGTGAGCATCTGCTCATGTATC TGGAGAAAGAGGCTTTGGAACAGAAAGACAGGGAGGATTTCGTACCCTTCACAGGAGAAAAGAAAGGGAGAGTCTTTATTCCCAAGGAAAAGCCTGTAGAAACTCGTAAAGAAGAGAAAGTGACTCTG GACCCAGAACTGGAGGAAGCCTTGGCCAGCGCCTCAGACACTGAACTCTACGACCTTGCAGCTGTCCTTGGAGTCCACAATTTGCTCAACAATCCGAAGTTTGATGAAGAAACAACCAATGGCCAAGG CCGCAAGGGGCCGGTGAGGAATGTCGTCAAAGGTGAAAAGGCCAAGCCGGTGTTTGAGGAGCCACCGAACCCCACAAATGTGGAAGCAAGCCTGCAGCAGATGAAAGCCAACGACCCCAGCCTGCAGG AGGTCAACCTCAACAACATTAAGAACATTCCAATTCCAACCCTGAAGGAGTTTGCAAAGGCTCTGGAGACCAACACCCACGTGAGGAAGTTCAGCCTGGCCGCAACCCGAAGCAATGACCCTGTGGCC CTGGCCTTTGCAGAGATGCTGAAGGTCAACAAGACCTTGAAAAGTCTGAATGTAGAGTCCAATTTTATCACCGGCGCTGGGATCCTGGCCCTGGTGGAAGCGCTGCGGGAGAATGACACCTTGACAGA GATCAAGATCGACAACCAGAGGCAGCAGTTGGGAACAGCCGTGGAGATGGAGATCGCCCAGATGCTGGAGGAGAACTCAAGGATCCTCAAGTTTGGGTACCAGTTTACCAAGCAAGGGCCACGGACAA GAGTGGCAGCTGCCATCACAAAAAATAATGACCTAGTTCGCAAGAAGAGAGTTGAAGGAGACAGGAGGTAAACCTCCACTAAAAGAGGTGACGTCTCACCATGCGGCCATCCAGAAAAACATACACAC AATCTTCCTCTTCTCCACGGGACCATTCTGTCTAAGGCTGTTCGTTTCCGTTAACCATATCCGTCATAATTGTAACTGTCACTCTTTTTTTAGCGCTACTTGTTTATCCAAGGTTCTGAAGTGTGTGT AGCAGTCTGCCTCGCTCCTGGACACGCTTGGTGGCTTGTACAAGTAGGAGGATACAGATCTTAAGACAGTGACAACACTGGAGATGATCTTAGCCACTTCCCTATTGGGTTGCCTCGCTTTCTTATGT GAACCTTTTTTAATCGTGGAAAGGGACTTAGCGTGTAGCATGTGTTTGTCGCTGACTGCACAGTGGAAGCCTATCTCTGTTTACACACACGGCTTCGAGATAGGCTTGAGTTCATGAGAAGTGTGTGC GACTGACCACACAAGAAGTTAGTATTGCCAGTCTTTCACAAATTCTCCGTTAATTCCAGAAAGAAAAAAAAAAGTGTCTCTACATGCATGTGTCCAGCTGATAGATGGTCAGTGGGATCTCCTTAGAA AGCACTTTAACGTAGCACTAGCAAAAGGACTGTTTATTACCCCATGATTTATTAATAACTCACACACTTACCTTTACTGACTTTTAAACATGAGTTAAACATATTTGTTTAGGTGTGTGGTACTGGGA ACTGTACCCTGGGCCCTGTGCATGCTGGGCAAGCACTCTACTCCTCAGCTCCATCTCCAGCCCGAGTTATATTTAAAATGATTCTCTAATAGGAACTATTCACAAAGCCATTGAAAGACTTTTCAATG GGAAACTTTTAAATTTTTTCTAAAAGAAAATTTCAAAATGGTACATTCCCAAGTAAAACAACTATAACAGTGTCTTAGGGGCGAGAGAAATGGCTCAGCCGTTAAAAGTGCTTGCTACTTTTCCAGAG GACCGGAGTTCAGTTTCAGCACCCGGGCTGAGCAGCTAACAATAGTGTATAACTCCATCTTCTGAGGGATGCGATGTCTCCAGCCTCTGAGGGCATCCACACATATGTGTACTTACCACCCCCATGTC ATACACATGATTAAAAATAGACTTAAAAGATATGGCACCTTAATCAAAGTTTCTGGTACACAGTGAATTTGACAGTGAATTAAATGAATTTGACAAATTTTAAAA
hide sequence
RefSeq Acc Id:
NP_113801 ⟸ NM_031613
- UniProtKB:
P70566 (UniProtKB/Swiss-Prot), A6I1E0 (UniProtKB/TrEMBL), A0A8I5ZMG0 (UniProtKB/TrEMBL)
- Sequence:
MALPFQKGLEKYKNIDEDELLGKLSEEELKQLENVLDDLDPESATLPAGFRQKDQTQKAATGPFDREHLLMYLEKEALEQKDREDFVPFTGEKKGRVFIPKEKPVETRKEEKVTLDPELEEALASASD TELYDLAAVLGVHNLLNNPKFDEETTNGQGRKGPVRNVVKGEKAKPVFEEPPNPTNVEASLQQMKANDPSLQEVNLNNIKNIPIPTLKEFAKALETNTHVRKFSLAATRSNDPVALAFAEMLKVNKTL KSLNVESNFITGAGILALVEALRENDTLTEIKIDNQRQQLGTAVEMEIAQMLEENSRILKFGYQFTKQGPRTRVAAAITKNNDLVRKKRVEGDRR
hide sequence
RefSeq Acc Id:
XP_006243469 ⟸ XM_006243407
- Peptide Label:
isoform X1
- UniProtKB:
P70566 (UniProtKB/Swiss-Prot), A6I1E0 (UniProtKB/TrEMBL), A0A8I5ZMG0 (UniProtKB/TrEMBL)
- Sequence:
MALPFQKGLEKYKNIDEDELLGKLSEEELKQLENVLDDLDPESATLPAGFRQKDQTQKAATGPFDREHLLMYLEKEALEQKDREDFVPFTGEKKGRVFIPKEKPVETRKEEKVTLDPELEEALASASD TELYDLAAVLGVHNLLNNPKFDEETTNGQGRKGPVRNVVKGEKAKPVFEEPPNPTNVEASLQQMKANDPSLQEVNLNNIKNIPIPTLKEFAKALETNTHVRKFSLAATRSNDPVALAFAEMLKVNKTL KSLNVESNFITGAGILALVEALRENDTLTEIKIDNQRQQLGTAVEMEIAQMLEENSRILKFGYQFTKQGPRTRVAAAITKNNDLVRKKRVEGDRR
hide sequence
RefSeq Acc Id:
XP_006243470 ⟸ XM_006243408
- Peptide Label:
isoform X1
- UniProtKB:
P70566 (UniProtKB/Swiss-Prot), A6I1E0 (UniProtKB/TrEMBL), A0A8I5ZMG0 (UniProtKB/TrEMBL)
- Sequence:
MALPFQKGLEKYKNIDEDELLGKLSEEELKQLENVLDDLDPESATLPAGFRQKDQTQKAATGPFDREHLLMYLEKEALEQKDREDFVPFTGEKKGRVFIPKEKPVETRKEEKVTLDPELEEALASASD TELYDLAAVLGVHNLLNNPKFDEETTNGQGRKGPVRNVVKGEKAKPVFEEPPNPTNVEASLQQMKANDPSLQEVNLNNIKNIPIPTLKEFAKALETNTHVRKFSLAATRSNDPVALAFAEMLKVNKTL KSLNVESNFITGAGILALVEALRENDTLTEIKIDNQRQQLGTAVEMEIAQMLEENSRILKFGYQFTKQGPRTRVAAAITKNNDLVRKKRVEGDRR
hide sequence
RefSeq Acc Id:
XP_008764553 ⟸ XM_008766331
- Peptide Label:
isoform X1
- UniProtKB:
P70566 (UniProtKB/Swiss-Prot), A6I1E0 (UniProtKB/TrEMBL), A0A8I5ZMG0 (UniProtKB/TrEMBL)
- Sequence:
MALPFQKGLEKYKNIDEDELLGKLSEEELKQLENVLDDLDPESATLPAGFRQKDQTQKAATGPFDREHLLMYLEKEALEQKDREDFVPFTGEKKGRVFIPKEKPVETRKEEKVTLDPELEEALASASD TELYDLAAVLGVHNLLNNPKFDEETTNGQGRKGPVRNVVKGEKAKPVFEEPPNPTNVEASLQQMKANDPSLQEVNLNNIKNIPIPTLKEFAKALETNTHVRKFSLAATRSNDPVALAFAEMLKVNKTL KSLNVESNFITGAGILALVEALRENDTLTEIKIDNQRQQLGTAVEMEIAQMLEENSRILKFGYQFTKQGPRTRVAAAITKNNDLVRKKRVEGDRR
hide sequence
Ensembl Acc Id:
ENSRNOP00000014124 ⟸ ENSRNOT00000014124
Ensembl Acc Id:
ENSRNOP00000079258 ⟸ ENSRNOT00000118239
Date
Current Symbol
Current Name
Previous Symbol
Previous Name
Description
Reference
Status
2002-06-10
Tmod2
tropomodulin 2
Name updated
70584
APPROVED
Note Type
Note
Reference
gene_expression
mRNA and protein expressed predominantly in brain
61770
gene_physical_interaction
protein binds to the neuron-specific isoform of tropomyosin (Tmbr3)
61770